Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/Explore/US Market Price/Stocks/DGX
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Quest Diagnostics Inc (DGX) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Quest Diagnostics (DGX) trades at $232.01, down 1.82% on the day but up significantly year-to-date. The stock shows strong earnings momentum with three consecutive quarterly beats, while technical indicators signal a bullish trend. Revenue growth accelerated to $11.04 billion in 2025, with net income reaching $992 million. Recent developments include a partnership with Apple Health and positive study results on tick-borne diseases.
The outlook remains positive with analyst consensus pointing to 7% upside to the $248.57 price target. Key opportunities include expanding diagnostic services and AI adoption, while risks center on potential Medicare reimbursement cuts and rising debt levels. Execution on growth initiatives will be crucial for sustaining momentum.
Read full analysis

Key Stats

  • Market Cap
    $26.23B
  • Volume
    1,030,388
  • Sector
    Health
  • 52W High
    $247.45
  • 52W Low
    $173.49
  • Typical Hold Time
    55 Days
  • Enterprise Value
    $31.98B
  • Div Yield
    1.45%
  • Trading Activity
    0% Sell | 100% Buy
$238.5
52W Low: $173.49
05 Jan 2026
52W High: $247.45
17 Sep 2026

Track Quest Diagnostics Inc (DGX) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Quest Diagnostics Inc has traded between a low of $173.49 and a high of $247.45, highlighting its annual price range. Buy and sell Quest Diagnostics Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About Quest Diagnostics Inc

Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.

Most Recent News

Content is generated by Aura AI

GameStop insiders buy millions in shares, signaling strong confidence despite stock volatility.

GameStop's CEO Ryan Cohen and other executives have made significant insider purchases of millions of shares, showing strong confidence in the company's future despite recent stock price volatility. These buys were active decisions, not pre-scheduled...

Market News
1 hour ago
Danny Green
Bullish
news icon
GameStop insiders buy millions in shares, signaling strong confidence despite stock volatility.

Iovance, SoundThinking, and WidePoint stocks surge on revenue upgrades, acquisition deal, and government contract news

Iovance Biotherapeutics shares jumped 31.48% after raising its 2026 revenue forecast, driven by strong demand for its cancer immunotherapy Amtagvi. SoundThinking's stock rose 50.09% following an acquisition agreement with Transom Capital Group, offer...

Market News
1 hour ago
Alex Lavoie
Bullish
news icon
Iovance, SoundThinking, and WidePoint stocks surge on revenue upgrades, acquisition deal, and government contract news

Stocks fall as uniQure, Fair Isaac, and ClearPoint Neuro lead losses on clinical and regulatory concerns.

Shares of uniQure dropped 37.33% following mixed clinical data for its Huntington's disease gene therapy. Fair Isaac fell 26.52% after U.S. regulators expanded the use of competitor VantageScore in mortgage credit scoring, threatening its market posi...

Market News
1 hour ago
Alex Lavoie
Bearish
news icon
Stocks fall as uniQure, Fair Isaac, and ClearPoint Neuro lead losses on clinical and regulatory concerns.
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions

All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $26.23B
  • Volume
    1,030,388
  • Sector
    Health
  • 52W High
    $247.45
  • 52W Low
    $173.49
  • Typical Hold Time
    55 Days
  • Enterprise Value
    $31.98B
  • Div Yield
    1.45%
  • Trading Activity
    0% Sell | 100% Buy
$238.5
52W Low: $173.49
05 Jan 2026
52W High: $247.45
17 Sep 2026

Track Quest Diagnostics Inc (DGX) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Quest Diagnostics Inc has traded between a low of $173.49 and a high of $247.45, highlighting its annual price range. Buy and sell Quest Diagnostics Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!